Anavex Life Sciences Corp. (AVXL)
Anavex Life Sciences Market Cap : 381.81M for Feb. 19, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Nephros, Inc. | 41.34M |
| Cabaletta Bio, Inc. | 302.27M |
| CorMedix, Inc. | 557.83M |
| Verastem, Inc. | 447.40M |
| Ocugen, Inc. | 520.44M |
Market Cap Related Metrics
| Price to Book Value | 3.015 |
| Price | 4.12 |
| Earnings Yield | -11.28% |